These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Qualitative and quantitative experimental models to aid in risk assessment for immunotoxicology. Luster MI; Pait DG; Portier C; Rosenthal GJ; Germolec DR; Comment CE; Munson AE; White K; Pollock P Toxicol Lett; 1992 Dec; 64-65 Spec No():71-8. PubMed ID: 1471226 [TBL] [Abstract][Full Text] [Related]
23. An evaluation of the decision tree approach for assessing priorities for safety testing of food additives. Phillips JC; Purchase R; Watts P; Gangolli SD Food Addit Contam; 1987; 4(2):109-23. PubMed ID: 3595920 [TBL] [Abstract][Full Text] [Related]
24. Adequate immunotoxicity testing in drug development. Herzyk DJ; Gore ER Toxicol Lett; 2004 Apr; 149(1-3):115-22. PubMed ID: 15093256 [TBL] [Abstract][Full Text] [Related]
25. Screening of toxic compounds in mammalian cell cultures. Ekwall B Ann N Y Acad Sci; 1983; 407():64-77. PubMed ID: 6349488 [TBL] [Abstract][Full Text] [Related]
26. Methods and approaches for assessing immunotoxicity: an overview. Dean JH; Luster MI; Boorman GA Environ Health Perspect; 1982 Feb; 43():27-9. PubMed ID: 7060546 [TBL] [Abstract][Full Text] [Related]
28. The use and acceptance of Other Scientifically Relevant Information (OSRI) in the U.S. Environmental Protection Agency (EPA) Endocrine Disruptor Screening Program. Bishop PL; Willett CE Birth Defects Res B Dev Reprod Toxicol; 2014 Feb; 101(1):3-22. PubMed ID: 24151143 [TBL] [Abstract][Full Text] [Related]
29. Use of an in vitro antibody-producing system for recognizing potentially immunosuppressive compounds. Archer DL; Smith BG; Bukovic-Wess JA Int Arch Allergy Appl Immunol; 1978; 56(1):90-3. PubMed ID: 618827 [No Abstract] [Full Text] [Related]
30. Immune system as a target organ for toxicity. Bick PH Environ Health Perspect; 1982 Feb; 43():3-7. PubMed ID: 7037386 [TBL] [Abstract][Full Text] [Related]
31. Testing strategies in mutagenicity and genetic toxicology: an appraisal of the guidelines of the European Scientific Committee for Cosmetics and Non-Food Products for the evaluation of hair dyes. Kirkland DJ; Henderson L; Marzin D; Müller L; Parry JM; Speit G; Tweats DJ; Williams GM Mutat Res; 2005 Dec; 588(2):88-105. PubMed ID: 16326131 [TBL] [Abstract][Full Text] [Related]
32. Assessment of immunologic alterations caused by halogenated aromatic hydrocarbons. Luster MI; Faith RE Ann N Y Acad Sci; 1979 May; 320():572-8. PubMed ID: 313178 [TBL] [Abstract][Full Text] [Related]
33. An ongoing validation of a Tier I screening battery for detecting endocrine-active compounds (EACs). O'Connor JC; Cook JC; Slone TW; Makovec GT; Frame SR; Davis LG Toxicol Sci; 1998 Nov; 46(1):45-60. PubMed ID: 9928668 [TBL] [Abstract][Full Text] [Related]
34. An enhanced tiered toxicity testing framework with triggers for assessing hazards and risks of commodity chemicals. Plunkett LM; Kaplan AM; Becker RA Regul Toxicol Pharmacol; 2010 Dec; 58(3):382-94. PubMed ID: 20709129 [TBL] [Abstract][Full Text] [Related]
35. Immunologic response and factors affecting its assessment. Moore JA; Faith RE Environ Health Perspect; 1976 Dec; 18():125-31. PubMed ID: 801132 [TBL] [Abstract][Full Text] [Related]
36. [Effects of antiepileptic drugs on immune system]. Basta-Kaim A; Budziszewska B; Lasoń W Przegl Lek; 2008; 65(11):799-802. PubMed ID: 19205364 [TBL] [Abstract][Full Text] [Related]
37. In vivo assays for immunotoxicity studies. Speirs RS Prog Clin Biol Res; 1984; 161():159-69. PubMed ID: 6483883 [No Abstract] [Full Text] [Related]
38. Prospective Environmental Risk Assessment for Sediment-Bound Organic Chemicals: A Proposal for Tiered Effect Assessment. Diepens NJ; Koelmans AA; Baveco H; van den Brink PJ; van den Heuvel-Greve MJ; Brock TCM Rev Environ Contam Toxicol; 2017; 239():1-77. PubMed ID: 26684744 [TBL] [Abstract][Full Text] [Related]
39. DISCRISET: a battery of tests for fast waste classification--application of tests on waste extracts. Deprez K; Robbens J; Nobels I; Vanparys C; Vanermen G; Tirez K; Michiels L; Weltens R Waste Manag; 2012 Dec; 32(12):2218-28. PubMed ID: 22770807 [TBL] [Abstract][Full Text] [Related]
40. Ex vivo and in vitro testis and ovary explants: utility for identifying steroid biosynthesis inhibitors and comparison to a Tier I screening battery. Powlin SS; Cook JC; Novak S; O'Connor JC Toxicol Sci; 1998 Nov; 46(1):61-74. PubMed ID: 9928669 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]